In BC, this large regulatory mechanism is orchestrated by Erα, which regulates the expression of several miRNAs, potentially contributing to sustain the proliferation and pathological features of cancer cells, providing a specific signature for ERα-positive and ERα-negative BCs [17,18,19]. Here, ESR1 is linked to breast cancer.